Does P-glycoprotein predict response to chemotherapy, and if so, is there a reliable way to detect it?

Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype.

Leukemia & lymphoma·2016

The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Oncogene·2015

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.

British journal of cancer·2014

Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.

Leukemia·2013

Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.

Oncogene·2011

Cancer incidence trends among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 2000-2022.

Journal of the National Cancer Institute·2026

Psychological distress in adult patients with colorectal cancer: roles of biological age and neighborhood deprivation.

Journal of the National Cancer Institute·2026

A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.

Journal of the National Cancer Institute·2026

Cancer rarity and mortality: Evidence from a nationwide cohort study.

Journal of the National Cancer Institute·2026

Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.

Journal of the National Cancer Institute·2026

Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.

Journal of the National Cancer Institute·2026

An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.

Neurological research·2026

Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026

Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.

Endocrine-related cancer·2026

Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Anesthesiology·2026

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

Cancer cytopathology·2026

PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.

Pakistan journal of pharmaceutical sciences·2026

Related Experiment Videos

Does P-glycoprotein predict response to chemotherapy, and if so, is there a reliable way to detect it?

Related Concept Videos

Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype.

The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.

Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.

Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.

Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.

Cancer incidence trends among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 2000-2022.

Psychological distress in adult patients with colorectal cancer: roles of biological age and neighborhood deprivation.

A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.

Cancer rarity and mortality: Evidence from a nationwide cohort study.

Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.

Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.

An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.

Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.

Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.

Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.

Related Experiment Videos

Does P-glycoprotein predict response to chemotherapy, and if so, is there a reliable way to detect it?

Related Concept Videos

Related Articles